News Directory

Keep up to date with MTPConnect news and events, updated regularly. If you have news or events the sector would be interested to hear about, please let us know at


07 February 2024

Recce Pharmaceuticals Establishes Strategic Partnership in South-East Asia to Accelerate Clinical Program

Recce Pharmaceuticals Limited has signed Memorandum of Understanding (MoU) with PT Etana Biotechnologies (Etana), a leading Indonesian biomedical organisation, to accelerate the clinical development of Recce’s anti-infective portfolio across Indonesia.

07 February 2024

In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To in January

Check out what MTPConnect got up to in January!

31 January 2024

First year of South Australia's Biomanufacturing Industry Doctoral Training PhD+ program is a success

Read our latest case study following the experiences of PhD students participating in the first year of the Biomanufacturing Industry Doctoral Training Centre (IDTC) PhD+ Program in South Australia. MTPConnect, through its Adelaide Intermediary Program (AIP), is delivering PhD Plus sessions as part of the biomanufacturing stream of the initiative.

24 January 2024

Calling Adelaide Healthtech Companies Wanting to Scale More Globally!

MTPConnect’s South Australian team is seeking Expressions of Interest from industry leaders to register their company for a new initiative to support ten emerging Adelaide City-based healthtech companies in the development of their business expansion plans.

24 January 2024

Join the Australian delegation to BIO2024 in San Diego, backed by MTPConnect

MTPConnect is excited to lead this year’s BIO2024 mission to San Diego from 3 – 6 June to showcase Australia’s outstanding life science innovations, innovators and unique biotechnology, pharmaceutical and manufacturing capabilities. Find out how to join the Australian delegation...

24 January 2024

How to nominate for the Prime Minister’s Prizes for Science in 5 easy steps

Show someone how much you value their contribution by nominating them for the 2024 Prime Minister’s Prizes for Science. Nominations open until 8 February 2024.

23 January 2024

Apply for UQ's Ventures Empower Program

Calling all entrepreneurs who are women and in the early stages of founding their startup!

17 January 2024

SA Insights Event: Funding Programs that drive Australia's healthtech innovations

Join host, Director for the Adelaide Intermediary Program, Jo Close, who will chat to six distinguished leaders, each representing national funding programs that drive Australia's healthtech innovations for the first SA Insights Event of 2024!

12 January 2024

In Case You Missed It: Here’s What The MTPConnect Team Has Been Up To in December

Check out what MTPConnect got up to in December!

11 January 2024

The Bridge Program – Applications Now Open!

The Bridge Program trains researchers and clinicians to navigate the pharmaceutical and biotech commercialisation pathway, as well as expanding their pharmaceutical commercialisation knowledge and networks. Find out more and apply now!

22 December 2023

BridgeTech Program Applications Open

Applications for the award-winning BridgeTech Program are now open for 2024!

21 December 2023

2023 Annual Report Out Now

Take a look at our 2023 Annual Report, out now!

20 December 2023

ASHRA Partnering Summit - Partnering for Translation and Building an Innovation Culture

MTPConnect’s TTRA program has co-hosted the Australian Stroke and Heart Research Accelerator (ASHRA) 2023 Annual Partnering Summit at the Victorian Heart Hospital in Clayton, Melbourne recently. With over 110 guests from industry, academia, research institutes, the health sector and government, it was an opportunity to learn, contribute and connect.

18 December 2023

WA Hub Kicks off New Year with Spotlight on Commercialising Medtech from a US and Australian Perspective

The WA Life Sciences Innovation Hub kicks off its first WA MTP Sector Spotlight Series event for 2024 with a fireside chat on medtech commercialisation from US and Australian perspectives with OncoRes Medicals' Jill Anderson and Dr Kath Giles.